Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the addition of the iPASSAGETM Retractor for Minimally Invasive Surgery (MIS) of the lumbar spine. The iPASSAGETM Retractor is a tissue sparing retraction system that allows the surgeon to make smaller incisions, potentially reducing tissue damage, blood loss and recovery time.
"We will continue to embrace and focus our product development on minimally invasive solutions," said John Winge, Executive Vice President of Sales and Marketing, Integra Spine. "Minutes matter when it comes to patient recovery time, and minimally invasive approaches may help decrease it."
To complement the iPASSAGETM Retractor, an MIS posterior discectomy preparation set is available for use with the Vu L-PODTM and Vu e-PODTM Intervertebral Body Fusion Device (IBD) systems. Additionally, the iPASSAGETM Retractor is compatible with the Paramount® MIS Pedicle Screw System and the Coral™ Spinal System's pedicle screws.
According to industry sources, the 2009 spinal minimally invasive market had an estimated value of $678 million in the United States.
The iPASSAGETM Retractor is distributed through Integra Spine, a leading provider of fusion implants and orthobiologics used in spinal surgery. Visit www.integraspine.com for more information.
Marty Makary, often wrong as pandemic critic, is poised to lead the FDA he railed against